✦ LIBER ✦

Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status

✍ Scribed by Zhong Wei; Wang Mengzhao; Zhang Li; Li Longyun; Zhang Xiaotong

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of gefitinib in advanced non-sm

✍ Gee-Chen Chang; Kun-Chieh Chen; Tsung-Ying Yang; Ming-Chang Yin; Ching-Pei Lin; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 54 KB

Evaluation of safety and efficacy of gef

✍ Xin-Lin Mu; Long-Yun Li; Xiao-Tong Zhang; Shu-Lan Wang; Meng-Zhao Wang 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 293 KB

Drug development in patients with advanc

✍ Thomas E. Stinchcombe; Mark A. Socinski 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Treatment approaches in patients with ad

✍ Ramaswamy Govindan; David H. Garfield 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Role of chemotherapy in patients with po

✍ Corey Langer; Rogerio Lilenbaum 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Management of patients with non-small ce

✍ Ramaswamy Govindan 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 194 KB